ReviewsMeta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee☆
Section snippets
Materials and methods
The literature review included a search of the databases of Excerpta Medica, Biosis, and MEDLINE, as well as a hand search of the relevant journals published between January 1969 (the start date of MEDLINE) and April 1995. The search was limited to English-language articles.
To be considered for inclusion, articles had to be original publications in a peer-reviewed journal, the subjects had to have urogenital atrophy, and the outcome of therapy had to be reported by one or more of the following
Results
Seventy-seven articles were reviewed and 58 were used for the meta-analysis. Of the 19 articles not used in the analysis, six did not contain outcomes that were considered in the meta-analysis, 11 had data that were inadequate for analysis, and two could not be classified appropriately.
Ten placebo controlled trials from nine articles were used to address the first aim of whether estrogen had a significant effect on urogenital atrophy. Table 2 describes the placebo controlled trials. From the
Discussion
Although this meta-analysis has clearly shown that estrogen therapy is beneficial for the treatment of symptoms and signs of urogenital atrophy, it is difficult to draw conclusions. The studies reviewed were heterogeneous and lacked standardization of patient selection, diagnostic criteria, study design, therapeutic intervention, follow up and, particularly, outcome variables. In addition, bias toward publication of positive results as well as variability in execution and implementation of
References (19)
- et al.
Prevalence of genitourinary and other climacteric symptoms in 61-year-old women
Maturitas
(1996) - et al.
Oestrogen therapy and the menopausal syndrome
Clin Obstet Gynecol
(1977) - et al.
Preoperative treatment with oestradiol in women scheduled for vaginal operations for genital prolapse. A randomised double blind trial
Maturitas
(1992) - et al.
Efficacy of sustained-release vaginal formulation of oestriol in alleviating urogenital and systemic climacteric complaints
Maturitas
(1991) - et al.
An epidemiological study of urinary incontinence and related urogenital symptoms in elderly women
Maturitas
(1990) - et al.
The effect of estriol on the cytology of urethra and vagina in postmenopausal women with genito-urinary symptoms
Eur J Obstet Gynecol Reprod Biol
(1993) Effects of protracted administration of oestriol on the lower genitourinary tract in postmenopausal women
Acta Obstet Gynaecol Scand
(1992)- et al.
Prevalence of genitourinary symptoms in the later menopause
Acta Obstet Gynaecol Scand
(1984) - et al.
Sexual dysfunction among middle aged women in the community
BMJ
(1988)
There are more references available in the full text version of this article.
Cited by (389)
Hormonal replacement in hypopituitarism in adults: An endocrine society clinical practice guideline
2016, Journal of Clinical Endocrinology and MetabolismTreatment of symptoms of the menopause: An endocrine society clinical practice guideline
2015, Journal of Clinical Endocrinology and MetabolismRecommendations for the management of postmenopausal vaginal atrophy
2010, ClimactericPostmenopausal hormone therapy: An endocrine society scientific statement
2010, Journal of Clinical Endocrinology and Metabolism
- ☆
- The authors thank Pharmacia and Upjohn for providing financial support for this study.
Copyright © 1998 The American College of Obstetricians and Gynecologists. Published by Elsevier Inc. All rights reserved.